|Other Names||Ubiquitin-like modifier-activating enzyme 6, Ubiquitin-activating enzyme 6, Monocyte protein 4, MOP-4, Ubiquitin-activating enzyme E1-like protein 2, E1-L2, UBA6, MOP4, UBE1L2|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin- E1 thioester and free AMP. Specific for ubiquitin, does not activate ubiquitin-like peptides. Differs from UBE1 in its specificity for substrate E2 charging. Does not charge cell cycle E2s, such as CDC34. Essential for embryonic development. Required for UBD/FAT10 conjugation. Isoform 2 may play a key role in ubiquitin system and may influence spermatogenesis and male fertility.|
|Tissue Location||Widely expressed. Isoform 2 is predominantly expressed in testis with higher expression in adult testis than in fetal testis.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Modification of proteins with ubiquitin (UBB; MIM 191339)or ubiquitin-like proteins controls many signaling networks andrequires a ubiquitin-activating enzyme (E1), a ubiquitinconjugating enzyme (E2), and a ubiquitin protein ligase (E3).UBE1L2 is an E1 enzyme that initiates the activation andconjugation of ubiquitin-like proteins (Jin et al., 2007 [PubMed17597759]).
Groettrup, M., et al. Trends Biochem. Sci. 33(5):230-237(2008)Chiu, Y.H., et al. Mol. Cell 27(6):1014-1023(2007)Pelzer, C., et al. J. Biol. Chem. 282(32):23010-23014(2007)Jin, J., et al. Nature 447(7148):1135-1138(2007)Hillier, L.W., et al. Nature 434(7034):724-731(2005)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.